1. 040 MS disease modifying therapy (DMT) sequencing – natalizumab to cladribine tablets – experience in 20 patients. Issue 6 (27th May 2022) Authors: Das, Joyutpal; Lewis, Thomas; Lusher, William; Vernon, Karen; Rog, David; Paul, Talbot; Sharaf, Nazar; Kalatha, Thaleia; Mihalova, Tatiana Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 6(2022) Page Start: A26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗